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http://dx.doi.org/10.1016/j.hkjn.201Summary This report examined the characteristics and trends of dialysis and renal transplant
patients among the resident population of Hong Kong who were managed by hospitals or dialysis
centers of the Hospital Authority, and accounted for approximately 95% of all patients receiving
renal replacement therapies (RRTs) in the territory. Patients receiving RRTs solely in the private
sector were not included in this report. Data trends from 1996 to 2011 are presented. In 2011,
1115 new patients were accepted into RRT programs, and the incident rate was 157 patients per
million populations (pmp). An increasing trend was noted. The incident rate was 95.1 pmp at the
commencement of the annual report in 1996. The point prevalence on December 31, 2012 was
8197 with a prevalence rate of 1152.5 pmp. Overall, there were 3573 patients (43.6%) on peri-
toneal dialysis (PD) and 1246 patients (15.2%) on hemodialysis (HD), and 3378 patients (41.2%)
were living with a functioning renal transplant. The PD/HD ratio was 74.2:25.8. The “PD First”
policy was continued. The overall mortality rate among RRT patients was 9.95 patients per 100
patient-years exposed. There was a decreasing trend in mortality among PD patients. Infection
and cardiovascular complications were the most common causes of death. Renal transplant was
the modality with the best survival rates. The 5 years cumulative patient survival rate fort of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Kowloon, Hong Kong Special
(Y.-W. Ho).
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Hong Kong renal registry report 2012 29patients on transplant treatment was 89.6%, whereas the corresponding patient survival rates
for PD and HD patients were 50.7% and 55.7%, respectively. More than 70% of RRT patients with
reports on rehabilitation were active and had normal daily activities.
本報告旨在審查在香港地區之透析及腎臟移植患者的狀況，這些患者均是香港居民，接受香港醫
院管理局轄下的醫院或透析中心所提供的治療，約佔當地腎臟替代療法 (RRT) 總病人數目的九成
半，僅在私營醫院接受 RRT 的患者並不包括在本報告之內。以下是 1996 年至 2011 年的數據趨
勢。在 2011 年，共有 1115 名新患者被納入 RRT 服務計劃，發生率為每百萬人口 157 人
(pmp)，比較在 1996 年的年度報告中發生率為 95.1 PMP，有增加的趨勢。截至2012年 12 月 31
日，點盛行個案為 8197，而患病率為 1152.5 pmp。當中有 3573 患者接受腹膜透析 (PD，
43.6%)，1246 患者接受血液透析 (HD，15.2%)，以及 3378 名患者接受腎臟移植後繼續存活
(41.2%)。PD 與 HD比例為 74.2：25.8，持續了優先採用腹膜透析治療之政策。RRT 患者的整體
死亡率為每 100 患者-年 9.95 人。PD 患者的死亡率呈下降趨勢。感染和心血管併發症是最常見
的死亡原因。接受腎移植患者的存活率為最高，5年累計之存活率達 89.6%，相對 PD 和 HD 患者
之存活率分別為 50.7%和 55.7%。超過七成的 RRT患者能維持正常的日常生活。Table 1 Renal centers and transplant clusters in Hong
Kong.
Hospital clusters Renal and satellite centers
Hong Kong West  Queen Mary Hospital
 Tung Wah Hospital
Hong Kong East  Pamela Youde Nethersole
Eastern Hospital
Kowloon Central  Queen Elizabeth Hospital
 Yau Ma Tei Satellite Center
Kowloon East  United Christian Hospital
 Tseung Kwan O Hospital
Kowloon West  Princess Margaret Hospital
 Kwong Wah Hospital
 Yan Chai Hospital
 Caritas Medical Center
New Territories East  Prince of Wales Hospital
 Alice Ho Miu Ling
Nethersole Hospital
 Northern District Hospital
New Territories West  Tuen Mun Hospital
 Tuen Mun Ambulatory
Dialysis Center
Transplant cluster hospitals
Queen Mary  Queen Mary Hospital
Hospital Cluster  Tung Wah Hospital
 Pamela Youde Nethersole
Eastern Hospital
 Kwong Wah Hospital
Queen Elizabeth  Queen Elizabeth Hospital
Hospital Cluster  Yau Ma Tei Satellite Center
 United Christian Hospital
 Tseung Kwan O Hospital
Princess Margaret  Princess Margaret Hospital
Hospital Cluster  Yan Chai Hospital
 Caritas Medical Center
 Tuen Mun Hospital
 Tuen Mun Ambulatory
Dialysis Center
Prince of Wales  Prince of Wales Hospital
Hospital Cluster  Alice Ho Miu Ling
Nethersole Hospital
 Northern District HospitalIntroduction
This report was based on the data (up to December 31,
2011) of dialysis and renal transplant patients from the
Renal Registry of the Hospital Authority (HA) of Hong Kong.
Approximately 95% of all patients who received renal
replacement therapy (RRT) in the territory were under the
HA, and patients who received RRT and followed up solely
in the private sector were not included in this report. There
are 12 renal units, two satellite centers, and four renal
transplant clusters in Hong Kong (Table 1).
First implemented in April 1995, the Renal Registry is an
online registry with data entered directly through Clinical
Management System computer terminals in wards or clinics
under the HA or through dedicated computer terminals in
renal units where patient data from individual renal units
can be retrieved and saved for service planning and patient
management use. The registry provides the necessary in-
formation for the HA head office in RRT service planning as
well as resource allocations. Because data are entered on-
line and renal units can update the data of their patients at
any time, there might be minor discrepancies in the Figures
retrieved during different periods.
The Renal Registry is part of the Organ Registry, Trans-
plant Systems (ORTS) and is linked with other computer
systems: the Organ Procurement System and the Trans-
plantation and Immunogenetics Laboratory System for
organ procurement, HLA mapping, as well as organ alloca-
tion in deceased donor renal transplantation.
The Renal Registry collects data from hospital dialysis
and transplant programs on patients from their first RRT
treatment for end-stage renal disease (ESRD; i.e., dialysis
or transplantation) to their death, unless they were lost to
follow-up. Only treatments provided in Hong Kong under
the HA were included in this report. Data were on a
calendar-year basis (January 1 to December 31).
Incident rates of RRT patients
In the year ending December 31, 2011, there were 1115
newly diagnosed patients with ESRD who were accepted
into RRT programs. The incidence rate was 156.96 patients
per million populations (pmp). There was a decrease in
Incident Rates, pmp, of different Modalities of RRT, 1996-2011
157
117
125
23
9
146, All RRT
147
148
132
149
146
141
136
138139
130
123
119
107
95
115, PD
107
118 118
116
118
110111110
116
108
106
92
81
 20, HD
15
181917
12131111
9
676
119
4 5
7 7
8
13
16 15
18
16
16
10
11
11
11, RTx
0
20
40
60
80
100
120
140
160
180
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Figure 1 Incident rates (permillionpopulation) by calendar year ofpatients accepted into renal replacement therapy (RRT)programs,
1996e2011. AllZ all patients on renal replacement therapy; HDZ hemodialysis; PDZ peritoneal dialysis; RTxZ renal transplant.
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Figure 2 Age-stratified trends in incident counts by calendar year, 1996e2011.
Median Age of Incident Patients on different Modes of RRT, 1996 - 2011
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Figure 3 Trends in median age for incident renal replacement therapy (RRT) patients, 1996e2011. HD Z hemodialysis;
PD Z peritoneal dialysis.
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Figure 4 Trends in mean age for incident renal replacement therapy (RRT) patients, 1996e2009. HD Z hemodialysis;
PD Z peritoneal dialysis.
Hong Kong renal registry report 2012 31the number of patients accepted into RRT programs in the
year 2009, but the trend resumed an increasing pattern in
subsequent years (Fig. 1). The commencement of the
promotion in advance care planning and supportive care
for patients who did not accept RRT was likely to be the
cause for the reduction in incident count and rates in
2009, but the increasing trend advanced further in the
year 2011.
In 2011, the mean and median age for incident RRT pa-
tients were 59.2 and 60.3, respectively, whereas those for
incident PD patients were 59.9 years and 61.0 years,
respectively. There were increasing trends in incident pa-
tient groups aged 45e64 years and 75þ years, whereas
rates for the other age groups were steady (Fig. 2).
The mean and median age for incident patients on PD,
HD, and renal transplant were gradually increasing (Figs. 3Percentage Male Sex Distribution, Incide
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Figure 5 Sex distribution: percentage distribution of males in in
replacement therapy (RRT). HD Z hemodialysis; PD Z peritonealand 4, respectively). This was in line with the increase in
population age in the territory. There were more male
patients accepting RRT, especially among the patients who
received preemptive renal transplant (Fig. 5). The trend in
male dominance in incident patients has remained steady
since 2001.
Diabetes mellitus (DM) remained the most common
primary etiology leading to ESRD, and the acceptance of
diabetic patients into RRT programs increased from 26.2%
in 1996 to 46% in 2011. They were generally older, with
median and mean age of incident diabetic patients
recorded as 62.6 years and 62.3 years, respectively.
Glomerulonephritis accounted for 17.8% of the primary
etiology. Hypertensive and other vascular causes were
responsible for 11.7% (Fig. 6), and the trend was
increasing.nt Patients, 3 modes of RRT, 1996 - 2011
2004 2005 2006 2007 2008 2009 2010 2011
cident patients, 1996e2011, among the three modes of renal
dialysis.
Trends in Percentage of Incident Patients - by Diagnosis, 1996 - 2011
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Figure 6 Diagnosis distribution (% incident counts) of patients, 1996e2011.
32 Y.-W. Ho et al.Point prevalent of patients on RRT
As of December 31, 2011, 8197 people were registered in
the Renal Registry on RRT treatment, of which 3573
(43.6%), were receiving PD treatment, 3378 (41.2%) were
living with a functioning kidney transplant, and 1246Prevalence of All R
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Figure 7 Trends in point prevalent distribution of renal replacem
as of December 31 of each year from 1996 to 2011.(15.2%) were receiving HD (Fig. 7). The prevalence rate of
RRT as of December 31, 2011 was 1152.5 pmp. There was an
increasing trend in prevalence rates from 1996 to 2011, and
the prevalence of HD patients under the HA had increased
significantly since 2010 (Fig. 8). The rate of increase in
prevalent patients with functioning renal allograft hadRT, as of 31/12 each year
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Figure 8 Trends in prevalent rates (per million population) of renal replacement therapy (RRT), 1996e2011. HDZ hemodialysis;
PD Z peritoneal dialysis; RTx Z renal transplant.
Hong Kong renal registry report 2012 33slowed down, whereas PD resumed an increasing trend in
2010e2011.
The profile of prevalent ESRD patients in Hong Kong had
gradually changed over time. At the end of 2011, the
largest proportion of RRT patients were receiving PD
(43.6%), but the proportion was decreasing among the three
modes of RRT (Fig. 9) with an increasing proportion of pa-
tients with functioning renal transplant. In 1996, 28.9% of
RRT patients were having functioning renal transplants. The
proportion increased to 41.2% in 2011. There was also an
increase in the provision of HD service in the territory since
2009, from 12.5% in 2009 to 15.2% in 2011. In addition to HD
service provision by HA centers, a proportion of patients
receiving HD at charitable as well as private centers are
followed up at HA renal units.
The HD/PD ratio among dialysis patients increased from
19:81 in 2006 to 25.9:74.1 in 2011 (Fig. 10). WhenPrevalence of All RRT, a
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Figure 9 Trends in percentage distribution of point prev
HD Z hemodialysis; PD Z peritoneal dialysis; RTx Z renal transplexamining the dialysis treatment under HA centers only,
the ratio was 16.1:83.9 in 2006 and changed to 21.7:78.3 in
2011 (Fig. 11).Peritoneal dialysis
The PD First policy was maintained. As of December 31,
2011, a total of 3573 patients were on various types of PD
treatment with a prevalence rate of 502.4 pmp, comprising
74.1% of the dialysis population or 43.6% of all RRT patients.
The majority of PD patients received continuous ambula-
tory peritoneal dialysis (CAPD, n Z 3219; 90.1%; Fig. 12).
Moreover, the proportion of patients on automated PD
(continuous cyclic peritoneal dialysis, n Z 157, 4.4%;
nocturnal intermittent peritoneal dialysis, n Z 197, 5.5%)
had increased steadily in the past 5 years (Fig. 13). Bys of 31/12 each year
4 2005 2006 2007 2008 2009 2010 2011
All Renal
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All HD 
All PD
alence in renal replacement therapy (RRT), 1996e2011.
ant.
Proportion of PD to HD among Prevalent Dialysis Patients, as of 31/12 each year
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Figure 10 Peritoneal dialysis/hemodialysis (PD/HD) ratio for all registered patients in Hospital Authority, including HD in
charitable and private centers, 1996e2011.
Proportion of PD to HD among Prevalent Dialysis Patients Receiving Dialysis under
HA, as of 31/12 each year
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Figure 11 Peritoneal dialysis/hemodialysis (PD/HD) ratio for dialysis patients in Hospital Authority centers, 1996e2011.
Point Prevalence- Peritoneal Dialysis- as of 31/12/2011
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Figure 12 Distribution of different types of peritoneal dial-
ysis (PD) as of December 31, 2011. CAPD Z continuous ambu-
latory PD; CCPD Z continuous cyclic PD; NIPD Z nocturnal
intermittent PD.
34 Y.-W. Ho et al.contrast, the number of CAPD patients had a negative
growth in the year 2009 but resumed a rising trend in the
past 2 years. From the year 2000 onward, there was gradual
switching from connecting PD system to disconnect sys-
tems. By 2009, all patients on PD were on disconnect
systems.Hemodialysis
There was a steady increase in the provision of HD service
to support patients who failed in PD treatment. The trend
was further increased with the reintroduction of home
femodialysis in the form of nocturnal home hemodialysis
(Fig. 14). As of December 31, 2011, 725 patients (60.7%)
were on regular HD in hospital settings under the HA, 76
Point Prevalence, Peritoneal Dialysis, 1996 - 2011, as of 31/12 each year
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Figure 13 Trends (prevalent counts) in the different types of peritoneal dialysis (PD), 1999e2011. CAPD Z continuous ambu-
latory PD; CCPD Z continuous cyclic PD; NIPD Z nocturnal intermittent PD.
Trends in Point Prevalence of Home and In-center HD , 1996 - 2011
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Figure 14 Trends (prevalent counts) of in-center hemodialysis (HD) and home HD, 1996e2011.
Prevalence of Renal Transplants - Followed up at HA Centres , pmp
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Figure 15 Trends (point prevalence, per million population) in renal transplantation, 1996e2011. DDRTZ deceased donor renal
transplantation; LDRT Z living donor renal transplantation.
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New Transplants Performed, by Calendar Year 1996 - 2011 
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Figure 16 Trends in new transplant stratified by the type of transplant and the place where the transplant operation was per-
formed, 1996e2011. DDRTZ deceased donor renal transplantation; HKZ Hong Kong; LDRTZ living donor renal transplantation.
36 Y.-W. Ho et al.individuals (6.1%) were on HD at satellite centers, 89 pa-
tients (7.1%) received HD treatment under a collaborative
publiceprivate program, 71 individuals (5.7%) were on
home HD, and 254 patients (20.4%) were dialyzed at char-
itable or private HD centers. The prevalence of HD was
175.2 pmp, comprising 25.9% of all dialysis patients or
15.2% of all RRT patients.Kidney transplantation
The prevalent count of patients with functioning renal
allograft continued to rise (Fig. 15), but the proportion
among RRT patients decreased in the past 2 years (Fig. 9)
comprising 41.2% of RRT patients with a prevalence rate of
474.9 pmp. Two years ago (in 2009), they were 42.7% and
462.2 pmp, respectively, whereas 10 years ago (2001),
they were 33.9% and 266.7 pmp, respectively. Among the
3378 patients with functioning graft on December 31,Number and Percentage of Prevale
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Figure 17 Trends in the number and percentage of di2011, 1081 patients (32%) underwent transplantation in
Hong Kong, whereas other transplants were performed
overseas. Of the transplants done in Hong Kong, 739
(68.4%) were deceased donor renal transplants (DDRTs)
and 342 (31.6%) were living donor renal transplants
(LDRT).
In the year ending December 31, 2011, 181 patients
commenced transplant treatment, of which 58 were DDRTs
procured among HA hospitals. There was a decreasing trend
in deceased donor kidney transplant in recent years
resulting in a reduction in the proportion of functioning
transplant among prevalent RRT patients (Fig. 16).
Commissioned training on living donor transplant was
organized in January 2011; the workshop on LDRT con-
ducted later in the territory resulted in an increase in the
number of LDRTs, and the increase persisted in the year
2012. Moreover, owing to activities that promoted organ
donation, the number of DDRTs done in Hong Kong had
increased to 84 in the year 2012.nt Dialysis Patients on ESA, as of 31/12
- 2011
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alysis patients on erythropoietin (EPO), 1996e2011.
Trends in Prevalent Percentage - by Diagnosis, 1996 - 2011
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Figure 18 Distribution (% prevalent patient counts) of primary diagnoses, 1996e2011.
Trends in Comorbidities, HBsAg anti-HCV & DM, 1996 - 2011
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Figure 19 Comorbidities (hepatitis B virus, hepatitis C virus, and diabetes mellitus) among prevalent patients, 1996e2011.
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Figure 20 Annual mortality rates per 100 patient-years, 1999e2011. HDZ hemodialysis; PDZ peritoneal dialysis; RRTZ renal
replacement therapy; RTx Z renal transplant.
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Mortality on RRT - Percentage by Causes of Death 1999- 2011
26.7% 26.7%
23.0% 23.0% 25.7%
28.9% 28.6% 30.0% 31.0% 30.3%
23.5%
19.5% 20.5%
29.2% 26.9%
30.4% 31.4%
32.4%
32.6% 34.6%
34.4% 31.5%
28.5%
31.0%
31.2%
36.0%
25.9% 29.0% 28.8% 24.9%
24.2%
24.7% 23.4% 19.7% 23.2% 28.1%
33.3%
35.1%
8.0% 6.8% 6.4%
7.1%
6.5%
6.2% 5.5%
6.7% 6.4%
4.7% 4.9% 5.6% 6.6%
2.6% 4.0% 3.6% 7.9% 4.1%
2.5% 3.3% 5.3% 3.9% 4.8% 3.7% 4.7% 5.0%
28.5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Sucide /
Accidental death
Liver failure
Fail / Termination
of dialysis
Malignancies
Cerebrovascular
Other / Unknown
Infection
Cardiovascular
Figure 21 Trends in cause of death for all renal replacement therapy patients, 1999e2011.
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Figure 22 Patient survival in peritoneal dialysis patients,
1995e2009.
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Figure 23 Patient survival in peritoneal dialysis patients,
1997e2001 vs. 2002e2006.
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The number of patients placed on erythropoiesis stimu-
lating agents (ESAs) had increased steadily throughout the
years. In 1996, only 29.3% of dialysis patients were reported
to be on ESAs. With the improvements in funding, 2686 of
4819 (55.7%) dialysis patients were on ESA treatment
(Fig. 17). On December 31, 2012, the number of patients on
ESAs was 3104.Diagnosis and comorbidities
The pattern of disease and comorbidities changed with the
changing environment and aging community. Diabetes is
currently the leading primary diagnosis among incident ESRD
patients. In prevalent patients, the proportion of diabetes
and hypertension increased from 12.9% and 3.6%, respec-
tively, in 1996 to 26.3% and 7.9%, respectively, in 2011
(Fig. 18). The proportions of other diagnoses were similar
throughout the years. The prevalence of hepatitis C virus
carrier continued the decreasing trend from 6.7% in 1996 toPD treatment status - Still on PD since commencement
2002 - 2006 combined
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Figure 24 Peritoneal dialysis (PD) treatment status, still on
PD 1e5 years after PD commencement, 2002e2006 combined.
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Figure 25 Trends in peritoneal dialysis (PD) peritonitis rates (patient-months per episode), 1999e2011. APD Z automated PD;
CAPD Z continuous ambulatory PD; CCPD Z continuous cyclic PD; NIPD Z nocturnal intermittent PD. Ultrabag is a disconnect
system by Baxter and Fresenius Z Stay Safe and Andydisc and Stay Safe Balance combined.
Hong Kong renal registry report 2012 391.9% in 2011, and the prevalence of hepatitis B virus carrier
was 9.3% in 2011, a percentage close to the prevalence rate
of the population. Diabetes as comorbidity (including DM as
primary etiology of ESRD and DM coexisted with the primary
etiology) was also rising among prevalent patients; it
increased from 20.8% in 1996 to 33.7% in 2011 (Fig. 19).Outcomes
Annual mortality rates were calculated by counting the
number of deaths divided by the person-years exposed. The
mortality rates of patients on PD, HD, and renal transplant
were 15.21 deaths, 19.45 deaths, and 2.00 deaths per 100
patient-years, respectively, in the year 2011. The overallFigure 26 Trends in causative microorganisms of peritonitis dumortality rate was 9.95 deaths per 100 patient-years, which
was steady throughout the years despite an aging RRT
population.
There was a decreasing trend in mortality in PD patients,
whereas the mortality of transplant recipients had
increased in the past 3 years (Fig. 20). Better dialysis care
and patients’ choices on either dialysis or supportive
management might be the reasons behind the improve-
ments. The increasing trend in mortality among HD patients
and transplant recipients might reflect the increasing
number of elderly patients who switched to HD after PD
failure or received renal transplant.
Cardiovascular, infection, and unknown causes were the
most common causes of deaths. The proportion of
“unknown” causes of death decreased in 2011, wherease to continuous ambulatory peritoneal dialysis, 1999e2011.
Trends of Some Important Microbiological Organisms in CAPD peritonitis
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Figure 27 Common microorganisms involved in continuous ambulatory peritoneal dialysis peritonitis, 1999e2011.
MRSA Z methicillin-resistant Staphylococcus aureus; MSSA Z methicillin-sensitive S. aureus.
40 Y.-W. Ho et al.malignancies were increasing as a cause of death among
RRT patients (Fig. 21).
As for patient survivals, the overall 1 year cumulative
patient survival for patients who commenced PD treatment
from January 1, 1995 to September 30, 2009, was 91.1%;
meanwhile, for 3 years, 5 years, and 10 years patient0.000
0.250
0.500
0.750
1.000
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Patient Survival, Hemodialysis with HD commences 1.1.1995 - 31.12.2009
Duration in Years
Su
rv
iva
l P
ro
ba
bi
lity
0.839
0.756
0.683
0.557
0.376
Figure 28 Hemodialysis (HD) patient survival, 1995e2009.
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Figure 29 Overall renal transplantpatient survival, 1995e2011.survival, this rate was 69.6%, 50.7%, and 26.7%, respec-
tively, with a median survival time of 5.1 years (Fig. 22).
When we compared the two groups of patientsdthose who
commenced PD treatment between 1997 and 2001 (97e01)
and those who commenced treatment from 2002 to 2006
(02e06)dthe overall patient survival in the 97-01 group
was better with a 5-year survival rate of 52%, whereas the
5-year survival rate for the 02-06 group was 48.4%
(pZ 0.001) (Fig. 23). There were demographic differences
between the two groups, with a higher median age as well
as a higher percentage of diabetes or hypertension as the
primary etiology of ESRD in the 02-06 group.
When we examined the percentage of patients who
commenced PD treatment between 2002 and 2006
(n Z 3858) and stratified them by age at commencement,
we noted that 31.3% (n Z 1209) were still on PD after 5
years.
For the 45e64 age group, 36.4% of patients were still on
PD 5 years later, whereas the Figures for the 65e74 and
75þ age groups were 28% and 19.4%, respectively (Fig. 24).
Of the 3573 prevalent PD patients on December 31,
2011, 109 (3.1%) had been on PD treatment for 10 years or0.000
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Figure 30 Graft survival, death not censored, living donor
renal transplantation (LDRT) vs. deceased donor renal trans-
plantation (DDRT), 1997e2006.
Patients Actively on Transplant Waiting List and % Diabetic, as of 31/12 each year
11.6%
15.9%
18.8%
22.6%
24.7%
10.9% 10.6%
14.1% 13.9% 14.4% 14.8%
31.3%30.6%
29.5%, % Diabetic,
28.6%28.2%
26.3%
All
DM
0%
5%
10%
15%
20%
25%
30%
35%
40%
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
%
 D
ia
be
tic
 o
n 
Tr
an
sp
la
nt
 L
ist
0
200
400
600
800
1000
1200
1400
1600
1800
N
um
be
r o
f p
at
ie
nt
s 
Ac
tiv
el
y 
on
 T
ra
ns
pl
an
t W
ai
tin
g 
Li
st
Figure 31 Trends in number of patients actively on transplant waiting list, as of December 31 of each year, and trends in the
percentage of diabetic patients on the waiting list. All Z all dialysis patients on waiting list; DM Z diabetes mellitus.
Hong Kong renal registry report 2012 41more. Of these 109 patients, 24 patients (0.7% of prevalent
PD patients) were on PD for 15e20 years and two patients
were on PD for more than 20 years.
The overall peritonitis rates for CAPD had improved from
22 patient-months per episode in 1999 to 35.8 patient-
months per episode in 2011. There were variations in the
peritonitis rates between different dialysis systems, and
the trends from 1999 to 2011 are presented in Fig. 25. In theFigure 32 Work status of all adult renal reyear 2011, patients on nocturnal intermittent peritoneal
dialysis performed best, with a peritonitis rate of 64.5
patient-months per episode (Fig. 25).
The pattern of microorganisms for CAPD peritonitis
remained relatively constant, although there was a gradual
increase in the proportion of patients with Gram-positive
microorganisms and a decreasing trend for culture negative
peritonitis. There were 48.2% Gram-positive organisms,placement therapy patients, 1999e2011.
Work Status of Adult Renal Replacement Therapy Patients, 1999 - 2011
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Figure 33 Trends in number of patients actively on transplant waiting list, as of December 31 of each year, age stratified.
42 Y.-W. Ho et al.35.8% Gram-negative organisms, and 11.1% culture negative
in the year 2011 (Fig. 26). On closer examination of several
common organisms, decreasing trends were noted in the
proportion of methicillin-resistant Staphylococcus and
Pseudomonas spp. (Fig. 27).
For patients who commenced HD between 1995 and 2011
(both HD as initial RRT as well as commencement of HD
after PD failure were included), an overall 1 year cumula-
tive patient survival rate of 83.9%, 3 years patient survival
of 68.3%, and 5 years patient survival rate of 55.7% were
noted, with a median survival time of 6.4 years (Fig. 28).
For patients who received DDRTs in Hong Kong between
1995 and 2009, the 1 year, 3 years, 5 years, and 10 yearsActivity Status of Patients on Renal Replacem
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Figure 34 Daily activities of living status of all adulpatient survival rates were 95.8%, 92.9%, 89.6%, and
80.1%, respectively (Fig. 29). The corresponding graft
survivals (death not censored) were 94.1%, 90.2%, 85.3%,
and 72.2%, respectively. When graft survivals (death not
censored) of LDRT were compared with survivals of DDRT,
LDRT was significantly better (p Z 0.0002, log rank test)
with a 1st year graft survival of 96.2%, 3 years graft survival
of 95.6%, 5 years graft survival of 93.5%, and 10 years graft
survival of 83.5% (Fig. 30). The 5 years patient survival for
LDRT was 95.5% and the 10 years patient survival was
91.7%, which are significantly better compared with the
corresponding rates of patients on DDRT (p Z 0.000, log
rank test).ent Therapy, 1999 - 2011
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Disabled
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t renal replacement therapy patients, 1999e2011.
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The number of patients actively on the transplant waiting
list increased steadily throughout the years, from 576 pa-
tients on December 31, 1996 to 1698 patients on December
31, 2012. The proportion of diabetic patients on the list
increased from 10.9% in 1996 to 31.3% in 2012 (Fig. 31). On
age stratification, there is an increasing trend in older
dialysis patients put on transplant waiting list (Fig. 32).
The percentage of patients on the active waiting list who
were hepatitis B surface antigen (HBsAg) positive ranged
between 8.5% and 10.8% from 1996 to 2012. The percentage
of HBsAg-positive patients actively on transplant waiting
list on December 31, 2011 and December 31, 2012 were
10.2% and 10.8%, respectively. The proportion coincides
with the prevalence of HBsAg-positive patients among
dialysis patients.
Rehabilitation
Work and daily activity status were recorded in the Renal
Registry. Based on records in the past 13 years, about 70%
of our patients were either working full time, working part
time, playing the role of a housewife, or retired. Disincli-
nation to work and absence from school were a minority
(Fig. 33). More than 80% of patients had normal activities.
Less than 10% of patients required assistance in their ac-
tivities in daily living (Fig. 34).
Discussion
The PD First policy in Hong Kong was started in 1985 and
has since been maintained. This had allowed a high prev-
alent rate of RRTs in the population. The number of pa-
tients who started on PD had declined in the year 2009 but
resumed a rising trend since the year 2010. The number of
patients on HD was increasing, secondary to the increase in
the timely switching of PD failure patients to HD treat-
ment. The number of transplant, especially those per-
formed overseas, had decreased, and the increase in
prevalence of dialysis patients overtook the increase in
transplant patients. The mean/median age of dialysis pa-
tients as well as the prevalence of diabetes patientsincreased. Diabetes was the major principle diagnosis of
ESRD leading to RRTs, and the increasing trend continued.
The future goal of the medical and nephrology community
will be the better management of diabetic patients and the
prevention of renal failure. The number of LDRTs as well as
DDRTs performed in Hong Kong remained low; further
awareness in organ donation and in the procurement of
living kidney donors is required.
The overall survival of RRT patients in Hong Kong is
comparable with that found in other parts of the world, and
the PD First policy did not have trade-offs in patient
survivals.Note
It is also important to note that all data presented in this
report are subject to change based on future data sub-
missions or corrections. Analytical conventions used in this
report may vary from previously published reports. Discrep-
ancies from previously published reports may reflect data-
base updates and/or differences in analytical approaches.Acknowledgments
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